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INTRODUCTION 
The United States Department of Energy (U.S. DOE) has recently implemented a series 
of strategic initiatives to address long-term radiological surveillance needs at former U.S. 
nuclear test sites in the Marshall Islands. The plan is to engage local atoll communities 
in developing shared responsibilities for implementing radiation protection monitoring 
programs for resettled and resettling populations in the northern Marshall Islands. Using 
the pooled resources of the U.S. DOE and local atoll governments, individual 
radiological surveillance programs have been developed in whole body counting and 
plutonium urinalysis in order to accurately assess radiation doses resulting from the 
ingestion and uptake of fallout radionuclides contained in locally grown foods. 
Permanent whole body counting facilities have been established at three separate 
locations in the Marshall Islands including Rongelap Atoll (Figure 1). These facilities are 
operated and maintained by Marshallese technicians with scientists from the Lawrence 
Livermore National Laboratory (LLNL) providing on-going technical support services. 
Bioassay samples are collected under controlled conditions and analyzed for plutonium 
isotopes at the Center for Accelerator Mass Spectrometry at LLNL using state-of-the art 
measurement technologies. We also conduct an on-going environmental monitoring and 
characterization program at selected sites in the northern Marshall Islands. The aim of 
the environmental program is to determine the level and distribution of important fallout 
radionuclides in soil, water and local foods with a view towards providing more accurate 
and updated dose assessments, incorporating knowledge of the unique behaviors and 
exposure pathways of fallout radionuclides in coral atoll ecosystems. These scientific 
studies have also been essential in helping guide the development of remedial options 
used in support of island resettlement. 
Together, the individual and environmental radiological surveillance programs are 
helping meet the informational needs of the U.S. DOE and the Republic of the Marshall 
Islands. Our updated environmental assessments provide a strong scientific basis for 
predicting future change in exposure conditions especially in relation to changes in life-
style, diet and/or land-use patterns. This information has important implications in 
addressing questions about existing (and future) radiological conditions on the islands, in 
determining as well as the implementation, cost and effectiveness of potential  
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Figure 1. Whole body counting system on Rongelap 
Island with a plastic calibration phantom sitting in the 
chair. 
 
intervention options, and in general policy support considerations. Perhaps most 
importantly, the recently established individual radiological surveillance programs 
provide affected atoll communities with an unprecedented level of radiation protection 
monitoring where, for the first time, local resources are being made available to monitor 
resettled and resettling populations on a continuous basis. 
As a hard copy supplement to Marshall Islands Program website (http://eed.llnl.gov/mi/), 
this document provides an overview of the individual radiation protection monitoring 
program established for resettlement workers living on Rongelap Island along with a full 
disclosure of all verified measurement data (2002-2004). Readers are advised that an 
additional feature of the associated web site is a provision where users are able 
calculate and track doses delivered to volunteers (de-identified information only) 
participating the Marshall Islands Radiological Surveillance Program.  
 
BRIEF HISTORY OF NUCLEAR TESTING IN THE MARSHALL ISLANDS 
Immediately after WWII, the United States created a Joint Task Force to develop a 
nuclear weapons testing program. Planners examined a number of possible locations in 
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the Atlantic Ocean, the Caribbean, and the Central Pacific but decided that coral atolls 
in the northern Marshall Islands offered the best advantages of stable weather 
conditions, fewest inhabitants to relocate and isolation with hundreds of miles of open-
ocean to the west where trade winds were likely to disperse radioactive fallout. During 
the period between 1945 and 1958, a total of 67 nuclear tests were conducted on Bikini 
and Enewetak Atolls and adjacent regions within the Republic of the Marshall Islands. 
The most significant contaminating event was the Castle Bravo test conducted on March 
1, 1954 (Figure 2). Bravo was an experimental thermonuclear device with an estimated 
explosive yield of 15 MT (USDOE, 2000), and led to widespread fallout contamination 
over inhabited islands of Rongelap and Utrōk Atolls, as well as other atolls to the east of 
Bikini. Today, the United States Department of Energy (U.S. DOE) through the Office of 
Health Studies continues to provide environmental monitoring, healthcare and medical 
services on the affected atolls. 
Key directives of the Marshall Islands Dose Assessment and Radioecology Program 
conducted at the Lawrence Livermore National Laboratory are (1) to provide technical 
support services and oversight in establishing radiological surveillance monitoring 
programs for resettled and resettling populations in the northern Marshall Islands; (2) 
to develop comprehensive assessments of current (and potential changing) 
radiological conditions on the islands; and (3) provide recommendations for 
remediation of contaminated sites and verify the effects of any actions taken 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Map of the Republic of Marshall Islands showing the fallout 
pattern from the Bravo nuclear test conducted on March 1 of 1954. 
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RONGELAP ATOLL 
People & Events | Resettlement of Rongelap Atoll  
 
 
People and Events on Rongelap Atoll 
On March 1, 1954 the United States conducted a nuclear test on Bikini Atoll in the 
northern Marshall Islands code named Bravo that led to widespread fallout 
contamination over inhabited islands of Rongelap, Ailingnae and Utrōk Atolls. Prior to 
Bravo, little consideration was given to the potential health and ecological impacts of 
fallout contamination beyond the immediate vicinity of the test sites. A total of 64 people 
living on Rongelap Atoll (including those people on Ailingnae Atoll) received significant 
exposure to radioactive fallout and had to be evacuated to Kwajalein Atoll for medical 
treatment. The Rongelap community spent the next 3 years living on Ejit Island (Majuro 
Atoll) before returning home to Rongelap in June 1957. However, growing concerns 
about possible long-term health effects associated with exposure to residual fallout 
contamination on the island prompted residents to relocate again to a new temporary 
home on Mejatto Island in 1985 (Kwajalein Atoll). The people of Rongelap are still 
resident on Mejatto today although parts of the community have split off to live on Ebeye 
Island (Kwajalein Atoll) or Majuro Atoll. 
The Rongelap community has always expressed a strong desire to return to their 
ancestral homeland. Through the Rongelap Resettlement Act, the U.S. Congress 
approved and continued a 1996 resettlement agreement between the United States and 
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the Rongelap Atoll Local Government, and extended distribution authority for ten years 
to advance resettlement. As a part of the 1996 resettlement agreement, a Phase I 
resettlement program was initiated in 1998. The U.S. Department of Energy, the 
Rongelap Atoll Local Government and the Republic of the Marshall Islands have since 
signed a Memorandum of Understanding (MOU, 1999) outlining shared provisions in 
support of resettlement. Under this agreement, scientists from the Lawrence Livermore 
National Laboratory were tasked with developing individual radiation protection 
monitoring programs for resettlement workers and to verify the effects of the remediation 
program. 
Resettlement of Rongelap Atoll 
Phase I resettlement of Rongelap Island is nearing completion. Rongelap Island now 
boasts a host of modern-day facilities including electrical power, a freshwater supply, a 
modern field station, a new runway, a whole-body counting facility and an adjoining 
health physics laboratory, and a large concrete pier.  
The remedial actions adopted under the Rongelap Resettlement Program are based on 
recommendations provided by scientists from the Lawrence Livermore National 
Laboratory. The remediation technique being employed is referred to as the combined 
option and involves replacing contaminated surface soil in the community area, where 
people spend most of their time, with a layer of clean crushed coral fill (Figure 3 & 4) and 
addition of potassium chloride fertilizer to the surrounding agricultural fields. Limited soil 
removal and addition of coral fill reduces external exposure to gamma/beta radiation as 
well as inhalation exposure to resuspended radioactive contaminants in the air that 
people breathe. The addition of potassium fertilizer to the agricultural areas partially 
blocks cesium-137 uptake into plants, especially into the fruits of the major subsistence 
crops such as coconut. It is expected that addition of potassium fertilizer on Rongelap 
Island will reduce the ingestion dose from 137Cs to less 20-30% of the pretreatment level 
and, at the same time, help support plant growth and increase the productivity of plants 
(see related information under Bikini Atoll). 
After living in exile for nearly 2 decades, the prospect that the people of Rongelap will 
soon return to their ancestral homeland is an important milestone in the history of the 
Marshall Islands Program. Moreover, the Rongelap resettlement program is among the 
first in which a local government has engaged the U.S. Department of Energy to develop 
shared provisions to monitor the return of the population. 
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Figure 3. Satellite image of Rongelap Island showing (insert) the location of the 
community center where surface soil was removed and replaced with clean 
crushed coral fill (approximately 11.4 ha or 36.1 acres). The initial phase of this 
work was completed in March 2001. A detailed in-situ gamma monitoring survey 
of the entire area was conducted in May 2001. The results of this study show 
that the combination of limited soil removal and addition of crushed coral fill was 
very effective in reducing the external exposure rates. The clean surface layer 
of coral also has the added benefit of reducing potential exposures from 
inhalation and ingestion of plutonium and/or other long-lived radionuclides 
present in the soil (Hamilton et al., 2001). 
 
Figure 4. View of the village area on Rongelap Island after the addition of 
crushed coral fill and showing view with the restored church in the 
background.  
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WHOLE BODY COUNTING 
What is Whole Body Counting? | What Will the Whole Body Counting Show? | 
Estimating Doses from Cesium-137 Based on Whole Body Counting | Doses to 
Rongelap Resettlement Workers from Internally Deposited Cesium-137 
What is Whole Body Counting?  
The whole body counting systems installed in the Marshall Islands contain large volume 
sodium iodide radiation detectors that measure gamma rays coming from radionuclides 
deposited in the body. The detector systems are modeled after the ‘Masse-Bolton Chair’ 
design (Figure 3) and can be used to detect high-energy gamma-emitting radionuclides 
from the decay of cesium-137, cobalt-60 and potassium-40 in most of the body and all of 
the internal organs. Using established protocols the whole body counting measurement 
data are converted into an annual effective dose using specially designed computer 
software (Canberra, 1998a; 1998b). 
There are currently three operational whole body counting facilities in the Republic of the 
Marshall Islands including Rongelap Island. The whole body counting systems are 
calibrated using a mixed-gamma point source. The point source calibration procedure 
was developed by cross-reference to a Bottle Man-akin Absorption (BOMAB) phantom 
(or human surrogate) calibration source containing a standard mix of gamma-emitting 
radionuclides traceable to the U.S. National Institute of Standards and Technology 
(NIST). 
Wherever possible, the whole body counting program in the Marshall Islands is 
conducted using the same quality requirements as established under the U.S. 
Department of Energy Laboratory Accreditation Program (DOELAP) for internal 
dosimetry. Background and other quality control check counts are performed on a daily 
basis to ensure that the measurement system conforms to all applicable quality 
requirements. Also, each whole body counting facility participates in external 
performance testing exercises with the Hazards Control Department at the Lawrence 
Livermore National Laboratory using ‘5 bottle phantoms’ prepared under contract by the 
Oak Ridge National Laboratory. These performance test samples are distributed around 
each of the facilities including a mirror whole body counting system located at Livermore. 
The performance of the facilities is then evaluated by comparing results with those 
obtained by the Hazards Control Department at the Lawrence Livermore National 
Laboratory−a DOELAP accredited facility−and with the reference values supplied by the 
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Oak Ridge National Laboratory. Under this quality assurance program, the data returned 
by these remote facilities in the Marshall Islands has consistently exceeded ANSI 13.30 
criteria for measurement accuracy and precision.  
Local Marshallese technicians are responsible for all daily operations within the facilities 
including scheduling of personal counts, performing systems performance checks, data 
reduction, and reporting to program volunteers (Figure 5). The technicians receive an 
initial six weeks of intensive training at the Lawrence Livermore National Laboratory and 
are employed to run the facilities for up to 40 hours per week. Scientists from the 
Lawrence Livermore National Laboratory provide on-going technical support services, 
advanced training in whole body counting and basic health physics, and perform a more 
detailed data quality assurance appraisal before the data are released in reports or 
posted to the world-wide web. 
 
 
 
 
Figure 5. Whole body counting technician, Mr. Ericson Arelong, working in 
the Rongelap Whole Body Counting Facility. 
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What Will the Whole Body Counting Show? 
The main pathway for exposure to residual fallout contamination in the northern Marshall 
Islands is through ingestion of cesium-137 contained in locally grown foods such as 
coconut, Pandanus fruit and breadfruit. The strategic objective of the whole body 
counting program in the Marshall Islands is to offer island residents an unprecedented 
level of radiation protection monitoring until it is clearly demonstrated that radiation 
surveillance measures can be relaxed. The value of this type of radiation protection 
monitoring program lies in the fact that whole body count data provides a direct measure 
of the full range of radionuclide uptakes into the local population. Information about 
potential high-end health risks and seasonal fluctuations in the body burden of cesium-
137 within exposed Marshallese can be assessed from measurement data rather than 
relying on a range of assumptions from different dietary scenarios. 
In combination with environmental monitoring data, residents who receive a whole body 
count showing the presence of cesium-137 can now make an informed decision about 
their eating habits or life-style based on what is considered a “safe” or acceptable health 
risk. The Republic of the Marshall Islands Nuclear Claims Tribunal has adopted a 
standard for cleanup of radioactively contaminated sites of 0.15 millisievert (mSv) per 
year (or 15 mrem per year) [EDE, Effective Dose Equivalent] using a lifetime cancer risk 
criterion recommended by the U.S. Environmental Protection Agency (EPA). As 
displaced communities return to their ancestral homelands, the Marshall Islands Whole 
Body Counting Program will allow the U.S. Department of Energy to monitor the return of 
the people and help ensure that the radiation related health risks remain at or below 
these established standards. 
Estimating Doses from Cesium-137 Based Whole Body Counting 
People living in the Marshall Islands may be exposed to cesium-137 contained in their 
diets from eating locally grown food crop products such as coconut. Whole body 
counting provides a direct measure of the amount of cesium-137 inside the body of 
people. The biokinectic behavior of cesium-137 inside the human body is well known 
and allows information from the whole body counter to be converted to a radiation dose. 
The radiation dose is what is used to quantify the potential human health risk associated 
with radiation exposure. The dosimetric data displayed in graphics presented in this 
report and the associated web site are based on the calendar year committed effective 
dose equivalent (CEDE) from intakes of radionuclides in the year of measurement 
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projected over 70 years [Appendix 3, see under Daniels et al., (2006)]. Dose equivalent 
is given in units of rem, the conventional units used by federal and state agencies in the 
United States. The SI unit of dose equivalent is the joule per kilogram or sievert (Sv). 
Doses from exposure to environmental radioactivity (natural or manmade) are normally 
expressed as 1/1000th of the base unit, i.e., in millirem (mrem) or millisievert (mSv). 1 
mSv is equal to 100 mrem.  
INFORMATION NOTE 
We have recently updated our methodologies for computing doses from the whole body 
counting and plutonium urinalysis programs (refer to the Technical Basis Document, 
Daniels et al., 2006). This new methodology uses a 50 y dose commitment and complies 
more fully with ICRP methodology. The algorithms developed to allow users to compute 
doses directly from the measurement data made available on the web site are also 
consistent with this new methodology.  
Doses to Rongelap Resettlement Workers from Internally Deposited Cesium-137 
The individual (de-identified) measurement data developed under the whole body 
counting program on Rongelap Island are tabulated in Appendix I, TABLE 1.  
The frequency distribution of the committed effective dose equivalent received by 
resettlement workers and other visitors to Rongelap Island (1999-2004) from exposure 
to dietary cesium-137, annualized to the year of measurement, is shown in Figure 6. 
The majority of resettlement workers and visitors to Rongelap Island received internal 
doses from intakes of cesium-137 of less than 1 mrem per year. The average committed 
effective dose equivalent for each year of measurement was 0.6±0.7 mrem in 1999 (N = 
41), 0.5 ±0.6 mrem in 2000 (N = 66), 0.3±0.5 mrem in 2001 (N= 102), 0.3±0.5 mrem in 
2002 (N=104), 0.3±0.7 mrem in 2003 (N=26), and 1.9±1.8 mrem in 2004 (N=36). The 
corresponding maximal individual committed effective dose equivalent for each year of 
measurement was 3.4 mrem, 3.4 mrem, 2.4 mrem, 2.3 mrem and 8.1 mrem, 
respectively. 
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Figure 6. Frequency distribution of the committed effective 
dose equivalent received by Rongelap resettlement workers 
from internally deposited cesium-137 annualized to the year 
of measurement (1999-2004). Summary graphics for each 
measurement year are based on the committed dose 
received over 70 year; refer supporting documentation 
(Daniels et al., 2006, Appendix 3).  
The committed effective dose equivalent for internally deposited cesium-137 in 
resettlement workers and other visitors to Rongelap can be compared with natural 
background doses of 140 mrem per year in the Marshall Islands and about 300 mrem 
per year in the United States. Rongelap resettlement workers are also receiving doses 
from ingestion of cesium-137 that are significantly below the annual dose criteria of 100 
mrem per year, excluding medical irradiation, imposed in 10CRF Part 20 (NRC, 1994) 
for protection of the public. Consequently, the whole body counting program on 
Rongelap appears to demonstrate that resettlement workers are not being exposed to 
significantly elevated levels of cesium-137in their diets. However, permanent residents 
living on Rongelap Atoll are more likely to adopt a traditional lifestyle and consume 
larger quantities of locally grown foods. Accordingly, we recommend that similar action 
be taken in developing a whole body counting program to monitor the return of the 
resettled population. 
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Schematic diagram of the systems configuration for measuring plutonium 
isotopes using Accelerator Mass Spectrometry (AMS). AMS is about 200 to 
400 times more sensitive than standard techniques commonly employed in 
routine internal dosimetry programs,  and far exceeds the standard 
requirements established under the latest United States Department of 
Energy regulation 10CFR 835 for in vitro bioassay monitoring of alpha-
emitting radionuclides such as plutonium-239. 
What is Plutonium Urinalysis Monitoring? 
Plutonium urinalysis is a very sensitive in-vitro bioassay measurement technique used to 
determine the amount of plutonium in human urine as a means of estimating the 
systemic burden (or total amount of plutonium) in the human body. Plutonium urinalysis 
tests are performed by collecting urine from individuals over a 24-hour period. The test 
turns a urine sample into a powder which scientists analyze by counting the number of 
plutonium atoms contained in the sample. Under the Marshall Islands Radiological 
Surveillance Program, we have developed a new state-of-the-art technology for 
measuring the amount of plutonium in urine based on Accelerator Mass Spectrometry. 
Everybody has a small amount of plutonium in their bodies. Plutonium occurs in nature 
at very low concentrations but human exposure to plutonium increased dramatically 
through the 1950s as a result of global fallout from atmospheric nuclear weapons 
testing. Marshall Islanders are potentially exposed to higher levels of contamination in 
the environment as a result of close-in and regional fallout deposition. 
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Routes of Exposure 
Plutonium is an important radioactive element produced in nuclear explosions. 
Plutonium emits alpha particles (or alpha-rays). Alpha-particles have a short range in 
tissue (about ~40 μm) and cannot be measured by detectors external to the body. 
However, as heavy slow moving charged particles they have a high relative 
effectiveness to disrupt or cause harm to the content of biological cells. As a 
consequence, in-vitro bioassay tests have been developed to test for the presence of 
systemic plutonium in the human body based on measured urinary excretion patterns 
and modeled metabolic behaviors of the absorbed isotopes. 
The main pathway for exposure to plutonium in humans is inhalation of contaminated 
dust particles in the air that people breathe. Inhaled or ingested plutonium may 
eventually end up in various organs–especially the lung, liver and bone–resulting in 
continuous exposure of these tissues to alpha particle radiation. Plutonium remains in 
the body for a long time but the systemic uptake of plutonium for people living in the 
northern Marshall Islands is still expected to be very low (Robison et al., 1980; 1982; 
1997). 
Inhalation exposure can be estimated from the product of the soil concentration, 
resuspension enhancement factors and inhalation dose conversion factors for 
radionuclides of interest. These estimates show that the projected dose contribution from 
exposure to plutonium in the Marshall Islands is less that 5% of the total lifetime dose 
from exposure to residual fallout contamination in the environment (Robison et al., 1980; 
1982; 1997). However, plutonium is a major concern to people living in the northern 
Marshall Island because of its long half-life and persistence in the environment. 
Radioactive debris deposited in lagoon sediments of coral atolls formed a reservoir and 
source term for remobilization and transfer of plutonium through the marine food chain 
and potentially to man. Also, elevated levels of plutonium in the terrestrial environment 
from close-in fallout deposition represent potential long-term inhalation and/or ingestion 
hazards. Early characterization of the terrestrial environment also revealed the presence 
of hotspots containing milligram-sized pieces of plutonium metal that clearly required 
some form of remediation (DOE, 1982). Consequently, dose assessments and atoll 
rehabilitation programs in the Marshall Islands have historically given special 
consideration to monitoring plutonium uptake in resettled and resettling populations. 
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What is the Purpose of Plutonium Urinalysis Monitoring in the Marshall Islands? 
Plutonium urinalysis is a measurement technique that ultimately provides information to 
individuals on the amount of plutonium they have in their bodies. Although plutonium is 
expected to be a minor contributor to the total manmade dose, it is a concern to people 
living in the northern Marshall Islands who are potentially exposed to elevated levels of 
plutonium in the environment from close-in or regional fallout deposition. Consequently, 
the United States Department of Energy has agreed to monitor resettlement workers and 
perform a limited number of urinalysis tests on island residents using advanced 
measurement technologies available at the Lawrence Livermore National Laboratory. 
The measurement technique currently employed at the Lawrence Livermore National 
Laboratory is based on Accelerator Mass Spectrometry. AMS is about 200 to 400 times 
more sensitive than monitoring techniques commonly employed in internal dosimetry 
monitoring programs in the United States, and far exceeds the standard requirements 
established under the latest Department of Energy regulation 10CFR 835 for in vitro 
bioassay monitoring of alpha-emitting radionuclides such as plutonium-239. 
The Marshall Islands Plutonium Urinalysis Monitoring Program was implemented under 
the following action criteria:- 
1) To provide more reliable and accurate data to assess baseline and potentially 
significant incremental uptakes of plutonium within resettled and/or resettling 
populations in the Marshall Islands. 
2) To monitor plutonium exposure in critical populations groups such as field 
workers engaged in soil remediation or agriculture. 
3) To determine occupational and/or public exposures to plutonium in the 
Marshall Islands and confirm they are below levels that will impact human 
health. 
4) To participate in analytical proficiency testing programs to ensure that the 
accuracy and reliability of our measurement data meets all applicable quality 
requirements and that procedures are carefully documented. 
5) To document and test the reliability of using environmental data to assess 
human exposure (and uptake) of plutonium in a coral atoll ecosystem. 
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Methods of Detection of Plutonium in Urine 
Researchers from the Brookhaven National Laboratory (BNL) were the first to use whole 
body counting and plutonium urinalysis techniques to assess intakes of internally 
deposited radionuclides in Marshallese populations (Sun et al., 1992; 1995; 1997a; 
1997b; 1997c; Conard 1982; Lessard et al., 1984; Miltenberger et al., 1981; Greenhouse 
et al., 1980). Classical methods for evaluating intakes of plutonium in bioassay samples 
include alpha-spectrometry and fission-track analysis. Alpha spectrometry cannot 
distinguish between plutonium-239 and plutonium-240, and results are normally reported 
for the sum of the two isotopes. Moreover, alpha spectrometry lacks the necessary 
detection sensitivity to accurately assess systemic plutonium uptake and dose in the 
Marshall Islands (Hamilton et al., 2004). Fission Track Analysis is limited to the 
quantification of plutonium-239 but with a reported detection limit (MDA, Minimum 
Detection Amount) of around 1 to 3 microBecquerel (μBq) of plutonium-239 offers 
greatly improved potential for assessing likely uptakes associated with low-level chronic 
exposure to plutonium in the environment.  
Under the Marshall Islands Plutonium Urinalysis Program, urine samples were initially 
sent to the University of Utah for analysis of plutonium using fission track analysis. 
Fission is a process where heavy nuclei such as plutonium and uranium break up into 
two large fragments. Fission may occur spontaneously or be induced by collisions with 
neutrons. During fission track analysis samples are exposed to a source of neutrons in a 
reactor in contact with a quartz or plastic slide. Any resulting fission fragments leave 
behind tracks on the slide that can be counted under an optical microscope to determine 
the amount of plutonium present. Historically, fission track analysis has been plagued 
with a number of deficiencies including the use of less than reliable and tedious 
preparative methods, low chemical yields, contamination issues and inaccurate 
quantification. The University of Utah and the Brookhaven National Laboratory improved 
on the fission track process methodology, and adopted a more rigorous approach to 
data reduction and quality assurance in support of urinalysis testing programs in the 
Marshall Islands.  
More recently, scientists from the Lawrence Livermore National Laboratory have 
developed a low-level detection technique for determination of plutonium isotopes in 
bioassay samples based Accelerator Mass Spectrometry (Brown et al., 2004; Hamilton 
et al., 2006). The technique has vastly improved the quality and reliability of 
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assessments of urinary excretion of plutonium by Marshall Islanders and avoids many of 
the disadvantages of using conventional atom counting techniques or other competing 
new technologies.  
INFORMATION NOTE 
There are two main isotopes of plutonium in the environment–namely plutonium-239 
(239Pu) and plutonium-240 (240Pu). The isotopic composition of plutonium (i.e., the 
relative amounts of 239Pu and 240Pu) may vary significantly depending on the source of 
plutonium. For example, the 240Pu/239Pu content of nuclear fallout from high−yield 
atmospheric nuclear tests in the Marshall Islands produced 240Pu/239Pu atom ratio 
signatures of ~0.3-0.35 compared with that present in integrated global fallout deposition 
(~0.18) or unfissioned nuclear fuel (~0.05). Consequently, it may be possible to use 
urinalysis testing and plutonium isotope measurements as an investigative tool to assess 
source specific exposures to Bravo as well as other nuclear test events.  
Method Validation 
Method validation is the process used to monitor and document the quality of the 
measurement data. Methods validation testing under the Marshall Islands Plutonium 
Urinalysis Program has included the labs participation in an interlaboratory exercise 
organized by the U.S. National Institute of Standards and Technology (NIST). The 
results of this exercise clearly demonstrate that Accelerator Mass Spectrometry is well 
suited for detection of μBq concentrations of plutonium-239 and plutonium-240 in urine 
(Figure 7) (Marchetti et al., 2002). An independent report on the results of this 
intercomparison exercise was recently published in the open scientific literature 
(McCurdy et al., 2005). 
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Figure 7. Results of a NIST interlaboratory exercise on 
determination of plutonium-239 in synthetic urine in the 
microBecquerel (μBq) range. 
We also continue to test the performance of the technique by analyzing externally-
prepared quality control natural urine samples artificially spiked with known amounts of 
plutonium. The quality control samples are prepared under contract with the Oak Ridge 
National Laboratory and analyzed along with routine bioassay samples collected from 
the Marshall Islands. The activity concentration of plutonium-239 in the quality control 
samples is kept below 200 μBq in order to avoid possible cross-contamination problems, 
and the plutonium-240/plutonium-239 atom ratio approximates that observed in 
integrated worldwide fallout deposition, i.e., ~0.2. The results of the quality control 
analyses are sent to Oak Ridge National Laboratory researchers for review who, in 
return, prepare a data quality assurance report. All quality control data must pass ANSI 
13.30 performance criteria for accuracy and precision before acceptance of any routine 
bioassay measurement data. The average combined measurement bias and precision 
based on spiked quality samples analyzed through March 2004 were -1.2% and ±5.1% 
for plutonium-239, and +6.1% and ±10.3% for plutonium-240, respectively. The results of 
the plutonium-239 measurements are shown in Figure 8. Based on the results from 
these performance tests we consider that the methodologies employed under the 
Marshall Islands Urinalysis Program to represent the current Dosimetric Data and 
Methodology. 
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Figure 8. Results of plutonium-239 measurements 
in externally-prepared natural matrix spiked quality 
control samples. 
Plutonium Urinalysis Monitoring on Rongelap 
The Individual (de-identified) measurement data developed under the Marshall Islands 
Plutonium Urinalysis Monitoring Program on Rongelap Island are tabulated in Appendix 
I, TABLE 2.  
The bioassay sampling program was designed to monitor the systemic uptake of 
plutonium into resettlement workers who were either actively involved in soil remediation 
or lived on Rongelap Island for extended periods as part of Phase I resettlement support 
operations. The geometric mean in the urinary excretion of plutonium-239 from 
resettlement workers stationed at Rongelap during the period between 1999 and 2003 
was ~0.2 μBq per 24-hour void (N = 171). This compares with a mean of -0.01 μBq of 
plutonium-239 measured in a comparable set of field blanks (N = 21, excluding one 
outlier) prepared and analyzed over the same period. A more detailed statistical analysis 
of these data will be given elsewhere (Bogen et al., 2006). 
Urinary excretion of plutonium from Marshallese populations will consist of a long-term 
baseline component from residual systemic burdens acquired from all previous 
exposures plus any prompt (new) contributions (and eventual long-term excretion) 
resulting from recently acquired systemic burdens of plutonium. It is estimated that 
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residents of the Northern Hemisphere have acquired sufficiently high systemic burdens 
of plutonium from exposure to global fallout contamination to produce urinary excretion 
rates of plutonium of around 2-4 μBq per 24-h void (Boecker et al., 1991). Based on 
fission track analysis of urine samples collected by scientists from Brookhaven National 
Laboratory, the systematic deposition of plutonium from exposure to global fallout 
contamination in the Marshall Islands is estimated to produce background urinary 
excretion rates of plutonium of around 1-2 μBq per 24-h void (National Research 
Council, 2004) or about an order of magnitude higher than levels observed in our 
studies. Consequently, we believe that higher quality bioassay data based on 
Accelerator Mass Spectrometry will provide a more accurate basis for assessing small 
incremental uptakes of plutonium in the resettled population on Rongelap. Similarly, the 
sensitivity of the method is such that we may be able to track long-term changes in the 
availability and transfer of plutonium through the marine and/or terrestrial pathways to 
man.  
The vast majority of the bioassay samples collected from Rongelap resettlement workers 
contained less than the critical level of plutonium to provide measurements with an 
acceptable level of precision and accuracy. Nonetheless, we can say that the systemic 
burden of plutonium in Rongelap resettlement workers is generally very low and well 
within the background range expected for people living elsewhere in the Northern 
Hemisphere. This would normally negate the necessity to assign doses to the individual 
measurements. However, for completeness, we attempt to assign a dose to all our 
measurement data using default assumptions (refer associated Technical Basis 
Document, Daniels et al., 2006). 
The range of estimates for the committed effective dose equivalent from systemic 
burdens of plutonium measured in resettlement workers temporarily housed on 
Rongelap for measurement years between 1999 and 2003 are shown in Figure 9. The 
committed dose shown in summary graphics on this web page is the dose received over 
70 years from the year of measurement; refer supporting documentation (Daniels, et al., 
2006, Appendix 3). Please note that the annualized dose criteria developed for 
remediation of radioactively contaminated sites (NCRP, 2004) is usually based on 
estimates of the total effective dose equivalent (TEDE) over 50 years and consists of the 
sum of the committed dose due to intakes of radionuclides during the measurement year 
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(of which, plutonium is just one potential component) and the deep dose equivalent from 
external exposures in that year. 
 
Figure 9. Frequency distribution of the committed effective 
dose equivalent from measured urinary excretion of 
plutonium by Rongelap resettlement workers during the 
year of measurement (1998 thru. 2003). Summary 
graphics are based on the committed dose received over 
70 years from the year of measurement; refer supporting 
documentation (Daniels et al., 2006, Appendix 3). 
Plans for the Future 
Some of the early urinary excretion data for plutonium in the Marshall Islands is of 
questionable quality because of the poor quantification sensitivity of the methods 
employed and/or general lack of adequate quality control. Consequently, we plan to 
collect additional bioassay samples from Rongelap Island to establish a baseline for 
those people resettling the island. After resettlement, any increase in the systemic 
burden of plutonium will result from very low-level chronic intakes of plutonium in food 
and/or soil or from inhalation of plutonium resuspended in the air. High quality baseline 
urinary excretion data will be required to provide a measure against which all future 
urinalysis tests on this population can be compared. Such provisions should help provide 
assurances to the resettled population that we will be able to adequately monitor the 
return of the population and assess any changes in the systemic uptake of plutonium 
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associated with resettlement. Similarly, high quality baseline data for Rongelap as well 
as for other resettled population groups, e.g., Utrōk Atoll population group, will provide 
value in helping confirm that the levels of plutonium in people living in the Marshall 
Islands are consistently low and well within the range expected from exposure to global 
fallout contamination, Additionally, by establishing an updated and well documented 
baseline for urinary excretion of plutonium, we will be better able to track and monitor 
potential long-term changes in exposure conditions on the atoll, especially in relation to 
the remobilization and transfer of plutonium through the aquatic food chain or from 
changes in land use patterns. 
MEASUREMENT DATA FROM THE INDIVIDUAL RADIOLOGICAL SURVEILLANCE 
PROGRAM 
Introduction | Individual Measurement Database
Introduction 
The individual (de-identified) measurement database developed in support of the 
Rongelap Resettlement Program is accessible over the world-wide web (Figure 10, 
http://eed.llnl.gov/mi/); 
Enewetak Measurem ent Data
SELECT YOUR PERSONAL ID
Rongelap Measurem ent Data
(includes resettlem ent workers)
SELECT YOUR PERSONAL ID
Select Personal IDSelect Personal ID
Select Personal ID
Utrok Measurem ent Data Other Marshall Islander Measurem ent Data
SELECT YOUR PERSONAL ID SELECT YOUR PERSONAL ID
subm it
subm itsubm it
subm itSelect Personal ID
 
Figure 10. Layout of the menu to access measurement data from our 
whole body counting and plutonium urinalysis programs over the world-
wide web (http://eed.llnl.gov/mi/). 
Whole-body counting provides a direct measure of the total amount of cesium-137 
present in the human body at the time of measurement. The amount of cesium-137 
detected is usually reported in activity units of kilo-Becequerel (kBq), where 1 kBq 
equals 1000 Bq and 1 Bq = 1 nuclear transformation per second (t s-1). The detection of 
plutonium-239 (239Pu) and plutonium-240 (240Pu) in bioassay (urine) samples indicates 
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the presence of internally deposited (systemic) plutonium in the body. At Livermore, 
these measurements are performed using a state-of-the-art technology based on 
Accelerator Mass Spectrometry (AMS) (Brown et al., 2004; Hamilton et al., 2004; 2006). 
Under the Marshall Islands Plutonium Urinalysis Program, the urinary excretion of 
plutonium from program volunteers is usually described in activity units, expressed as 
micro-Becquerel (μBq) of 239+240Pu (the sum of the 239Pu and 240Pu activity) excreted 
(lost) per day (d-1); where 1 μBq d-1 = 10–6 Bq d-1 and 1 Bq = 1 t s-1. 
Individual Measurement Database 
The website provides electronic access to verified whole body counting and plutonium 
urinalysis data developed under the Marshall Islands Radiological Surveillance Program 
at the Lawrence Livermore National Laboratory (1999-present). Please note that 
measurement data developed for Rongelap resettlement workers and other visitors to 
the island incorporates counts from all three of our whole body counting facilities and 
may include people from other affiliations with the exception of permanent residents from 
Enewetak and Utrōk Atolls. 
DOSIMETRIC DATA AND METHODOLOGY  
Introduction | Dose Methodology 
Introduction 
The individual (de-identified) dosimetric database developed in support of the Rongelap 
Atoll Resettlement Program is accessible over the world-wide web (Figure 11, 
http://eed.llnl.gov/mi/); 
Enewetak Dosim etric Data
SELECT YOUR PERSONAL ID
Rongelap Dosim etric  Data
(includes resettlem ent workers)
SELECT YOUR PERSONAL ID
Select Personal IDSelect Personal ID
Select Personal ID
Utrok Dosim etricData Other Marshall Islander Dosim etric Data
SELECT YOUR PERSONAL ID SELECT YOUR PERSONAL ID
subm it
subm itsubm it
subm itSelect Personal ID
 
Figure 11. Layout of the menu to access dosimetric data from our whole 
body counting and plutonium urinalysis programs over the world-wide web 
(http://eed.llnl.gov/mi/). 
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In general, nuclear transformations emit energy and/or particles in the form of gamma 
rays, beta particles and alpha particles. Tissues in the human body may adsorb these 
emissions with the potential for any deposited energy to cause damage and disrupt 
biological function of cells. The general term used to quantify the extent of any health 
risk from radiation exposure is referred to as the dose. The equivalent dose is defined by 
the average absorbed dose in an organ or tissue weighed by the average quality factor 
for the type and energy of the radiation causing the dose. The effective dose equivalent 
(as applied to the whole body) is the sum of the average dose equivalent for each tissue 
weighted by tissue weighing factors. The SI unit of effective dose equivalent is the joule 
per kilogram (J kg-1), named the sievert (Sv). The conventional unit often used by 
federal and state agencies in the United States is called a rem; 1 rem = 0.01 Sv.  
Based on measurements of the internally deposited 137Cs and/or the urinary excretion of 
plutonium, an estimate can be derived for either or both radionuclides of the annual 
number of nuclear transformations (t y-1) that occurred in the body during the 
measurement year. For both radionuclides, this result is the time integral of activity in the 
body of an individual normalized over a one-year measurement period. In addition to 
nuclear transformations occurring during the year of measurement, additional 
transformations may occur in the future due to the presence of residual activity in the 
body at the end of the measurement year. The number of transformations derived from 
the residual radioactivity is usually evaluated up to 50 y in the future (a conservative 
maximum as defined by the United States (U.S.) Environmental Protection Agency 
(EPA) for members of the public) resulting in a committed dose. Accordingly, these 
future transformations will commit additional dose to the individual according to the 
biological half-life of the radioactive element of concern. For this reason, it is considered 
appropriate and conforming with the national and international recommendations of the 
United States Environment Protection Agency (U.S. EPA) and the International 
Commission on Radiological Protection (ICRP) that this additional dose commitment be 
assigned to the year of measurement. Consequently, dose reports issued under the 
Marshall Islands Radiological Surveillance Program are based on the Committed 
Effective Dose Equivalent (CEDE). 
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Dosimetric Methodology 
The calendar year dose represents the sum of radionuclide-specific, age-dependent, 
committed effective dose equivalent for each monitored radionuclide. The total calendar 
years dose is calculated over a calendar year but only applies to the sum of the 
committed dose from cesium-137 and the 50-y integrated dose from plutonium (based 
on a time integral of any whole body counting and any available plutonium bioassay 
measurements performed during that year). When only one radionuclide is measured, 
the total dose assigned in a year and the CEDE for a specific radionuclide are identical. 
When more than one radionuclide is measured, the total annual ‘calendar year’ dose is 
the sum on the CEDE for each measured radionuclide. The calendar year dose 
estimates based on whole body counting and plutonium bioassay are conservative in 
nature, especially in relation to plutonium, and is only be comparable to the internal dose 
component of the EDE standard of 15 mrem per year as adopted by the Marshall Islands 
Nuclear Claims Tribunal for cleanup and rehabilitation of radioactively contaminated 
sites (to view the full report on the dose methodology, see Daniels et al., 2006). 
PROVIDING FOLLOWUP ON RESULTS
All volunteers participating in the Marshall Islands Individual Radiological Surveillance 
Program are issued preliminary copy of their dose report immediately after they receive 
a whole body count. Scientists from the Lawrence Livermore National Laboratory verify 
the measurement data and, if required, a revised dose report is generated and returned 
to the individuals concerned. Annualized doses of 10 mrem or above evoke a pre-
determined action or investigation. These actions may include follow-up verification 
measurements, a dietary evaluation and/or a work history review. Below this level, 
default assumptions for assigning doses (refer Daniels et al., 2006) are assumed to be 
valid and no further action is taken. Data may be withheld from the website while these 
investigations are on-going. Our action level is one-tenth of the investigation level used 
throughout the U.S. Department of Energy and is well below the 15 mrem per year 
standard adopted by the Republic of the Marshall Islands Nuclear Claims Tribunal for 
cleanup of radioactively contaminated sites. In addition, at the end of each calendar 
year, all program volunteers receive a final written report containing an estimate of their 
“calendar year dose”. 
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GLOSSARY OF TERMS 
Absorbed Dose 
The absorbed dose is the energy deposited in an organ or tissue per unit mass of 
irradiated material. The common unit for absorbed dose is the rad, which is equivalent to 
100 egs per gram of material. The international scientific community has adopted the 
use of different terms. The SI unit of absorbed dose is the joule per kilogram (J kg−1) 
and its special name is the gray (Gy). One Gy is the same as 100 rad. 
Activity 
Activity is the rate of transformation or decay of a radioactive material. The SI unit of 
activity is the reciprocal second (s−1) and its special name is the Becquerel. Federal and 
state agencies in the United States use conventional units where activity is given in 
curies (Ci); 1 Ci = 3.7 x 1010 Bq. 
Alpha Particles 
Alpha particles are one of the primary types of radiation associated with radioactivity and 
exist as energetic nuclei of helium atoms, consisting of two protons and two neutrons. 
Alpha rays are heavy, slow moving, charged particles that travel only one or two inches 
in air, and can be stopped by a piece of paper or the outer dead layer of human skin.  
Background Radiation  
The average person in the United States receives about 3.6 mSv (360 mrem) of ionizing 
radiation every year. About 3.0 mSv (300 mrem) per year comes from natural 
background radiation including cosmic radiation, radiation emitted by naturally occurring 
radionuclides in air, water, soil and rock, and radiation emitted by natural radionuclides 
deposited in tissues of organs; and  about (0.6 mSv) 60 mrem from man-made sources 
such as exposures to diagnostic X-rays and consumer products (e.g., from smoking 
tobacco). The general worldwide contribution from radioactive fallout contamination is 
<0.3% of the average total annual dose. Exposures to natural background radiation vary 
depending on the geographic area, diet and other factors such as the composition of 
materials used in the construction of homes. The natural background radiation dose in 
the Marshall Islands is around 1.4 mSv (140 mrem) per year and is significantly less 
than what most people receive around the world. 
Baseline 
We have all been exposed to some level of worldwide fallout contamination. In the 
United States, the general population receives up to 0.015 mSv (1.5 mrem) or about 
0.3% of the average total annual dose from exposure to worldwide fallout contamination 
from atmospheric nuclear weapons testing and about 0.005 (0.5 mrem) or about 0.1% of 
the average total annual dose from operations related nuclear power generation. 
Similarly, people living in the Marshall Islands will have very small quantities of internally 
deposited fallout radionuclides such as cesium-137, strontium-90 and plutonium in their 
bodies from worldwide contamination of food, air, water and soil. Assessments of 
possible increases in radiation exposure from elevated levels of fallout contamination in 
the northern Marshall Islands can only be made on the basis of comparisons with 
residual systematic burdens of radionuclides acquired from previous exposures to global 
fallout contamination. Under the Marshall Islands Radiological Surveillance Program, 
efforts are being made to improve on the reliability of measurements of background 
urinary excretion rates of plutonium from Marshallese populations against which the 
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results of future bioassay measurements can be compared to accurately assess the 
impacts of resettlement on radiation exposure and dose. 
Becquerel (Bq) 
A Becquerel (abbreviated as Bq) is the International System (SI) unit for activity of 
radioactive material. One Bq of radioactive material is that amount of material in which 
one atom is transformed or undergoes 1 disintegration every second. Whole body 
counting and plutonium bioassay measurements are usually reported in activity units of 
kBq (kiloBecquerel) (1000 x 1 Bq) and μBq (microBecquerel) (1×10−6 x 1 Bq), 
respectively. 
Biokinectic 
The word ‘biokinetic’ is used here to describe the adsorption (uptake), distribution and 
retention of elements in humans.   
Calibration 
Calibration is the process of adjusting or determining the response or reading of an 
instrument to a standard.   
Committed Dose Equivalent 
Committed dose equivalent is the time integral of the dose-equivalent rate in a particular 
tissue that will be received by an individual following an intake of radioactive material 
into the body by inhalation, ingestion or dermal absorption. For adults the committed 
dose is usually the dose received over 50 years. For children, the committed dose is 
usually calculated from the age of intake to age 70 years. For these age groups the term 
‘integrated dose equivalent’ is used. 
Committed Effective Dose Equivalent (CEDE) 
The committed effective dose equivalent is the committed dose equivalents to various 
tissues or organ in the body each multiplied by an appropriate tissue-weighing factor and 
then summed. The conventional unit for committed effective dose equivalence (CEDE) 
used by federal and state agencies within the United States is the rem. The international 
scientific (SI) unit of committed effective dose equivalent is called a sievert (Sv). One Sv 
is the same as 100 rem. 
Critical Level (Lc) 
The critical level is the amount of a count or final measurement of a quantity of an 
analyte at or above which a decision is made that the analyte is definitely present (Lc ≈ 
MDA/2). 
Default Assumptions (used in assignment of dose) 
The largest dose contributions attributable to exposure to residual nuclear fallout 
contamination in the Marshall Islands result from either internal exposure from intakes of 
radionuclides through ingestion, inhalation and/or absorption through the skin or external 
exposure from radionuclides distributed in the soil. External exposure rates can be 
measured directly using instrument surveys of the radiation field. The assignment of 
dose to internally deposited radionuclides is much more complicated. Biokinectic and 
dosimetric models developed by the International Commission on Radiological 
Protection (ICRP) are used to convert whole body burdens (from whole body counting or 
from in vitro bioassay tests such as urinalysis) into dose. In the case of a chronic 
exposure, organ and body burdens continue to build up over time until a steady state is 
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reached where losses due to decay and excretion are balanced by intake and 
absorption. Cesium-137 has an effective half-life in an adult of about 110 days, and 
under chronic exposure conditions reaches a maximal dose contribution after about 2 
years. By contrast, plutonium absorbed from the gastrointestinal or respiratory tract 
enters the blood stream and deposits in liver and bone with an effective half-life of 20 to 
50 years. Only a small fraction of plutonium entering the blood stream is excreted in 
urine with the long-term excretion rate approaching 2 x 10−5 of the systemic body 
burden per day. Knowledge of excretion rates and time of exposure are important when 
interpreting urinalysis data. A more detailed discussion of the dose calculation 
methodology is given elsewhere (see under Daniels et al., 2006). 
Direct bioassay 
The measurements of radioactive material in the human body utilizing instrumentation 
that detects radiation emitted from radioactive material in the body (synonymous with in 
vivo measurements).  
Dose Assessment 
The scientific process used to determine radiation dose and uncertainty in the dose.  
Dose Equivalent 
The dose equivalent is the adsorbed dose at a point in tissue multiplied by a biological 
effectiveness factor or quality factor for the particular types of radiation to cause 
biological damage. The conventional unit of dose equivalents used by federal and state 
agencies in the United States is the rem. A dose of 100 rem to an adult normally 
produces some clinical signs of radiation sickness and requires hospitalization. The 
international scientific unit for dose equivalent is the joule per kilogram (J kg−1) and is 
called the sievert (Sv). One Sv is the same as 100 rem. 
Effective Dose Equivalent 
The effective dose equivalent for the whole body is the sum of dose-equivalents for 
various organs in the body weighted to account for different sensitivities of the organs to 
radiation. It includes the dose from radiation sources internal and/or external to the body.  
The effective dose equivalent is usually expressed in units of millirem (mrem). The 
international scientific unit for dose equivalent is the joule per kilogram (J kg−1) and is 
called the sievert (Sv). One Sv is the same as 100 rem. 
External Dose or Exposure 
That portion of the dose equivalent received from radiation sources outside the human 
body. 
Fission Track Analysis 
During neutron irradiation heavy nuclei such as uranium and plutonium undergo nuclear 
fission with release of large fission fragments. This property has led to the development 
of a number of measurement techniques such as delayed neutron activation analysis 
and fission track analysis. Fission track analysis is a measurement technique commonly 
employed in plutonium urinalysis (bioassay) monitoring programs. Urine samples are 
chemically treated to remove plutonium. The plutonium is then mounted in contact with a 
special plastic or quartz slide known as solid-state nuclear track detector (SSNTD). The 
slide along with the sample is then irradiated in a reactor where neutron-induced fission 
of plutonium-239 (or uranium-235) causes emission of energetic fission fragments. 
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Some of the fragments penetrate into the SSNTD damaging the integrity of the material 
before coming to rest. The SSNTD is separated from the sample and chemically etched 
to expose the damaged areas (known as fission tracks) on the detector surface. The 
fission tracks are then counted under an optical microscope. The amount of plutonium 
(and/or uranium) present in the sample is a function of the total number of tracks and the 
neutron flux. 
Gamma-rays 
Gamma-rays are electromagnetic waves produced by spontaneous decay of radioactive 
elements during de-excitation of an atomic nucleus. Sunlight also consists of 
electromagnetic waves but gamma-rays have a shorter wavelength and much higher 
energy. High-energy gamma-rays such as those produced by decay of cesium-137 may 
penetrate deeply into the body and affect cells. Gamma-rays from a cobalt-60 source are 
often used for cancer radiotherapy. 
High-End Health Risk 
High-end health risk is used here under the context that it refers to the maximally 
exposed individuals in a population. 
In Vito 
In vitro measurements are synonymous with indirect bioassay techniques, such as 
plutonium urinalysis. 
In Vivo 
In vivo measurements are synonymous with bioassay techniques, such as whole body 
counting.  
Indirect bioassay 
In direct bioassay are measurements used to determine the presence of and/or the 
amount of a radioactive material in the excreta, urine or in other biological materials 
removed from the body (synonymous with in vitro measurements). 
Individual 
An individual is any human being. 
Internal Dose or Exposure  
The internal dose is that portion of the dose equivalent received from radiation sources 
inside the human body. 
Isotope 
Atoms with the same number of protons but different numbers of neutrons are called 
isotopes of that element. We identify different isotopes by appending the total number of 
nucleons (the total number of proton plus neutrons in the nucleus of an atom) to the 
name of the element, e.g., cesium-137. Isotopes are usually written in an abbreviated 
form using the chemical symbol of the element. Two examples include 137Cs for 
cesium-137 and 239Pu for plutonium-239.   
Minimum Detectable Amount (MDA) 
The minimum detectable amount (MDA) is the smallest activity or mass of an analyte in 
a sample or person that can be detected with an acceptable level of uncertainty. 
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Quality Assurance 
All those planned and systematic actions necessary to provide adequate confidence that 
an analysis, measurement or surveillance program will perform satisfactorily. 
Quality Control 
Quality Control is defined as those actions taken to control the attributes of a analytical 
process, system or facility according to predetermined quality requirements. 
Radiation Dose (or mrem)
A generic term to describe the amount of radiation a person receives. Dose is measured 
in units of thousands of a roentegen equivalent man (rem) (called the millirem). The 
conventional unit used by federal and state agencies in the United States is the millirem 
(mrem). Dose is a general term used to assist in the management of exposure to 
radiation. The common international scientific (SI) unit for dose is the millisievert (mSv). 
One mSv is the same as 100 mrem. 
Radioactivity 
A natural and spontaneous process by which unstable atoms of an element emit energy 
and/or particles from their nuclei and, thus change (or decay) to atoms of a different 
element or a different state of the same element. 
Radiological Monitoring 
Radiological monitoring is the process of measuring radiation levels or individual doses, 
and the use of the results to assess radiological hazards or potential and actual doses 
resulting from exposures to ionizing radiation. 
Remediation 
Remediation is the actions taken to reduce risks to human health or the environment 
posed by the presence of radioactive or hazardous materials. 
Risk 
The probability of harm from the presence of radionuclides or hazardous materials taking 
into account (1) the probability of occurrences or events that could lead to an exposure, 
(2) probability that individual or populations would be exposed to radioactive or 
hazardous materials and the magnitude of such exposures, and (3) the probability that 
an exposure would produce a response.  
Validation 
Validation refers to the process of defining the method capability and determining 
whether it can be properly applied as intended. 
Whole Body 
For the purposes of external exposure includes the head, trunk, the arms above and 
including the elbow, and legs above and including the knee.  
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Table 1. Whole body count data for resettlement workers on Rongelap Island (2002-2004). 
 
137Cs (kBq) 
Personal ID # 
Age 
Type Gender 
Collection 
Date Value MDA 
 
RR00007 Adult Male 2002-03-18 0.00 ± 0.00 0.08 
RR00007 Adult Male 2002-05-23 0.10 ± 0.02 0.12 
RR00007 Adult Male 2002-07-26 0.00 ± 0.00 0.08 
RR00007 Adult Male 2002-10-08 0.00 ± 0.00 0.08 
RR00009 Adult Male 2003-11-04 0.00 ± 0.00 0.11 
RR00012 Adult Male 2002-03-14 0.00 ± 0.00 0.08 
RR00012 Adult Male 2002-05-23 0.00 ± 0.00 0.08 
RR00012 Adult Male 2002-06-29 0.06 ± 0.02 0.12 
RR00026 Adult Male 2002-03-13 0.13 ± 0.02 0.12 
RR00026 Adult Male 2002-06-17 0.14 ± 0.02 0.13 
RR00026 Adult Male 2004-03-22 0.52 ± 0.05 0.21 
RR00026 Adult Male 2004-05-12 0.61 ± 0.05 0.20 
RR00029 Adult Male 2002-03-09 0.34 ± 0.02 0.13 
RR00029 Adult Male 2002-05-18 0.50 ± 0.03 0.13 
RR00029 Adult Male 2002-06-27 0.40 ± 0.02 0.13 
RR00029 Adult Male 2002-07-24 0.39 ± 0.02 0.13 
RR00029 Adult Male 2002-08-03 0.45 ± 0.02 0.13 
RR00029 Adult Male 2002-09-13 0.44 ± 0.02 0.12 
RR00029 Adult Male 2002-10-17 0.29 ± 0.02 0.11 
RR00029 Adult Male 2002-11-17 0.32 ± 0.02 0.13 
RR00029 Adult Male 2004-03-22 0.76 ± 0.05 0.19 
RR00029 Adult Male 2004-04-06 0.81 ± 0.05 0.20 
RR00029 Adult Male 2004-05-12 0.63 ± 0.05 0.20 
RR00029 Adult Male 2004-09-22 0.47 ± 0.04 0.18 
RR00030 Adult Male 2002-03-17 0.22 ± 0.02 0.12 
RR00030 Adult Male 2002-07-26 0.15 ± 0.02 0.12 
RR00030 Adult Male 2002-10-17 0.10 ± 0.02 0.11 
RR00030 Adult Male 2004-03-14 0.79 ± 0.05 0.18 
RR00030 Adult Male 2004-05-15 0.75 ± 0.05 0.20 
RR00030 Adult Male 2004-08-27 0.61 ± 0.05 0.20 
RR00030 Adult Male 2004-11-29 0.62 ± 0.05 0.19 
RR00030 Adult Male 2004-12-30 0.47 ± 0.08 0.34 
RR00032 Adult Male 2002-03-18 0.08 ± 0.02 0.10 
RR00032 Adult Male 2002-06-03 0.00 ± 0.00 0.08 
RR00032 Adult Male 2002-10-18 0.00 ± 0.00 0.08 
RR00034 Adult Male 2002-02-03 0.12 ± 0.02 0.11 
RR00034 Adult Male 2002-03-09 0.00 ± 0.00 0.08 
RR00034 Adult Male 2003-11-05 0.00 ± 0.00 0.11 
RR00038 Adult Male 2002-05-30 0.00 ± 0.00 0.08 
RR00038 Adult Male 2002-06-29 0.00 ± 0.00 0.08 
RR00038 Adult Male 2002-11-09 0.05 ± 0.02 0.13 
RR00038 Adult Male 2004-04-06 0.00 ± 0.00 0.07 
RR00038 Adult Male 2004-05-13 0.00 ± 0.00 0.07 
RR00051 Adult Male 2003-11-27 0.25 ± 0.02 0.18 
RR00051 Adult Male 2004-02-27 0.09 ± 0.03 0.15 
RR00054 Adult Male 2002-05-20 0.14 ± 0.02 0.13 
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Table 1. Continued. 
 
137Cs (kBq) 
Personal ID # 
Age 
Type Gender 
Collection 
Date Value MDA 
 
RR00054 Adult Male 2002-06-28 0.15 ± 0.02 0.12 
RR00054 Adult Male 2002-08-22 0.08 ± 0.02 0.11 
RR00054 Adult Male 2002-11-07 0.16 ± 0.02 0.12 
RR00057 Adult Male 2002-03-09 0.00 ± 0.00 0.08 
RR00065 Adult Male 2002-03-13 0.14 ± 0.02 0.12 
RR00065 Adult Male 2002-05-22 0.15 ± 0.02 0.12 
RR00065 Adult Male 2002-06-28 0.12 ± 0.02 0.12 
RR00065 Adult Male 2002-10-12 0.00 ± 0.00 0.08 
RR00066 Adult Male 2002-02-03 0.10 ± 0.02 0.12 
RR00066 Adult Male 2002-03-17 0.06 ± 0.01 0.10 
RR00066 Adult Male 2002-07-28 0.00 ± 0.00 0.08 
RR00066 Adult Male 2002-08-23 0.00 ± 0.00 0.08 
RR00066 Adult Male 2002-10-13 0.00 ± 0.00 0.08 
RR00069 Adult Male 2002-03-16 0.00 ± 0.00 0.08 
RR00069 Adult Male 2002-05-19 0.11 ± 0.02 0.13 
RR00069 Adult Male 2002-07-29 0.00 ± 0.00 0.08 
RR00069 Adult Male 2002-10-13 0.04 ± 0.02 0.11 
RR00069 Adult Male 2002-12-01 0.22 ± 0.02 0.13 
RR00071 Adult Male 2004-09-26 0.28 ± 0.04 0.19 
RR00072 Adult Male 2002-03-08 0.31 ± 0.02 0.12 
RR00072 Adult Male 2002-07-25 0.26 ± 0.02 0.12 
RR00072 Adult Male 2002-11-24 0.31 ± 0.02 0.13 
RR00072 Adult Male 2003-07-21 0.89 ± 0.03 0.18 
RR00072 Adult Male 2004-04-03 0.48 ± 0.05 0.21 
RR00072 Adult Male 2004-08-09 0.52 ± 0.05 0.21 
RR00073 Adult Male 2002-03-17 0.06 ± 0.01 0.11 
RR00073 Adult Male 2002-05-18 0.13 ± 0.02 0.11 
RR00073 Adult Male 2002-07-28 0.00 ± 0.00 0.08 
RR00073 Adult Male 2002-08-31 0.15 ± 0.02 0.13 
RR00073 Adult Male 2002-09-21 0.17 ± 0.02 0.11 
RR00073 Adult Male 2002-10-12 0.07 ± 0.02 0.11 
RR00073 Adult Male 2002-11-14 0.30 ± 0.02 0.12 
RR00073 Adult Male 2004-03-14 0.28 ± 0.04 0.16 
RR00073 Adult Male 2004-04-05 0.35 ± 0.04 0.19 
RR00073 Adult Male 2004-05-15 0.50 ± 0.05 0.21 
RR00073 Adult Male 2004-09-18 0.41 ± 0.04 0.18 
RR00076 Adult Male 2002-03-12 0.11 ± 0.02 0.13 
RR00076 Adult Male 2002-07-25 0.16 ± 0.02 0.12 
RR00076 Adult Male 2002-10-18 0.21 ± 0.02 0.12 
RR00076 Adult Male 2004-03-14 0.13 ± 0.03 0.13 
RR00076 Adult Male 2004-04-03 0.51 ± 0.05 0.21 
RR00076 Adult Male 2004-05-12 0.79 ± 0.05 0.21 
RR00076 Adult Male 2004-06-14 1.00 ± 0.05 0.21 
RR00078 Adult Male 2002-02-03 0.00 ± 0.00 0.08 
RR00078 Adult Male 2002-03-09 0.00 ± 0.00 0.08 
RR00078 Adult Male 2004-09-29 0.00 ± 0.00 0.07 
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Table 1. Continued. 
 
137Cs (kBq) 
Personal ID # 
Age 
Type Gender 
Collection 
Date Value MDA 
 
RR00081 Adult Male 2002-10-21 0.00 ± 0.00 0.08 
RR00088 Adult Male 2004-09-25 0.33 ± 0.05 0.20 
RR00089 Adult Male 2002-11-10 0.00 ± 0.00 0.08 
RR00098 Adult Male 2002-03-08 0.00 ± 0.00 0.08 
RR00098 Adult Male 2002-05-18 0.00 ± 0.00 0.08 
RR00098 Adult Male 2004-06-06 0.00 ± 0.00 0.07 
RR00098 Adult Male 2004-08-17 0.05 ± 0.03 0.12 
RR00098 Adult Male 2004-09-24 0.00 ± 0.00 0.07 
RR00111 Adult Male 2002-03-09 0.16 ± 0.02 0.12 
RR00111 Adult Male 2002-05-22 0.25 ± 0.02 0.12 
RR00111 Adult Male 2002-07-26 0.05 ± 0.02 0.11 
RR00111 Adult Male 2002-08-26 0.07 ± 0.02 0.11 
RR00111 Adult Male 2002-09-21 0.31 ± 0.02 0.13 
RR00111 Adult Male 2002-10-11 0.27 ± 0.02 0.13 
RR00111 Adult Male 2003-05-27 0.45 ± 0.02 0.13 
RR00120 Adult Male 2002-05-18 0.22 ± 0.02 0.12 
RR00120 Adult Male 2002-07-26 0.13 ± 0.02 0.12 
RR00121 Adult Male 2002-09-21 0.06 ± 0.02 0.11 
RR00121 Adult Male 2002-11-15 0.00 ± 0.00 0.08 
RR00121 Adult Male 2003-05-26 0.00 ± 0.00 0.08 
RR00122 Adult Male 2002-03-14 0.06 ± 0.01 0.11 
RR00123 Adult Male 2002-05-22 0.00 ± 0.00 0.08 
RR00124 Adult Male 2002-02-05 0.12 ± 0.02 0.12 
RR00124 Adult Male 2002-03-16 0.00 ± 0.00 0.08 
RR00124 Adult Male 2002-06-13 0.04 ± 0.02 0.10 
RR00124 Adult Male 2002-07-25 0.00 ± 0.00 0.08 
RR00124 Adult Male 2002-10-13 0.00 ± 0.00 0.08 
RR00124 Adult Male 2002-11-10 0.05 ± 0.02 0.12 
RR00125 Adult Male 2002-03-08 0.00 ± 0.00 0.08 
RR00125 Adult Male 2002-05-18 0.06 ± 0.02 0.11 
RR00125 Adult Male 2002-07-26 0.07 ± 0.02 0.13 
RR00126 Adult Male 2002-02-04 0.05 ± 0.01 0.11 
RR00126 Adult Male 2002-06-13 0.00 ± 0.00 0.08 
RR00126 Adult Male 2002-07-25 0.00 ± 0.00 0.08 
RR00128 Adult Male 2003-11-06 0.39 ± 0.03 0.18 
RR00128 Adult Male 2003-12-01 0.39 ± 0.03 0.18 
RR00130 Adult Male 2002-03-18 0.06 ± 0.02 0.12 
RR00130 Adult Male 2002-05-22 0.00 ± 0.00 0.08 
RR00130 Adult Male 2002-07-27 0.05 ± 0.02 0.12 
RR00130 Adult Male 2002-10-13 0.00 ± 0.00 0.08 
RR00132 Adult Male 2002-03-08 0.17 ± 0.02 0.12 
RR00132 Adult Male 2002-05-17 0.09 ± 0.02 0.11 
RR00132 Adult Male 2002-06-29 0.07 ± 0.02 0.11 
RR00132 Adult Male 2002-07-24 0.11 ± 0.02 0.12 
RR00132 Adult Male 2002-08-26 0.00 ± 0.00 0.09 
RR00132 Adult Male 2002-10-23 0.18 ± 0.02 0.12 
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137Cs (kBq) 
Personal ID # 
Age 
Type Gender 
Collection 
Date Value MDA 
 
RR00132 Adult Male 2004-01-14 0.44 ± 0.04 0.18 
RR00132 Adult Male 2004-04-05 0.53 ± 0.05 0.23 
RR00132 Adult Male 2004-06-05 0.57 ± 0.04 0.18 
RR00132 Adult Male 2004-08-27 0.56 ± 0.05 0.20 
RR00136 Adult Male 2004-05-11 1.38 ± 0.06 0.23 
RR00136 Adult Male 2004-08-31 1.80 ± 0.07 0.23 
RR00137 Adult Male 2002-03-08 0.23 ± 0.02 0.12 
RR00137 Adult Male 2002-05-17 0.64 ± 0.03 0.13 
RR00137 Adult Male 2002-06-27 0.42 ± 0.03 0.13 
RR00137 Adult Male 2002-08-28 0.46 ± 0.02 0.12 
RR00137 Adult Male 2002-09-13 0.66 ± 0.03 0.13 
RR00137 Adult Male 2002-10-17 0.47 ± 0.02 0.13 
RR00137 Adult Male 2002-11-13 0.36 ± 0.02 0.13 
RR00141 Adult Male 2002-03-13 0.00 ± 0.00 0.08 
RR00141 Adult Male 2002-05-18 0.00 ± 0.00 0.08 
RR00141 Adult Male 2002-06-29 0.00 ± 0.00 0.08 
RR00141 Adult Male 2002-07-26 0.05 ± 0.02 0.12 
RR00141 Adult Male 2002-10-12 0.00 ± 0.00 0.08 
RR00141 Adult Male 2002-11-15 0.00 ± 0.00 0.08 
RR00142 Adult Male 2004-09-26 0.19 ± 0.04 0.19 
RR00143 Adult Male 2002-02-04 0.08 ± 0.02 0.11 
RR00143 Adult Male 2002-07-25 0.00 ± 0.00 0.08 
RR00144 Adult Male 2003-11-27 0.53 ± 0.03 0.19 
RR00144 Adult Male 2004-02-27 0.46 ± 0.04 0.19 
RR00144 Adult Male 2004-11-05 0.12 ± 0.04 0.20 
RR00145 Adult Male 2002-03-08 0.00 ± 0.00 0.08 
RR00146 Adult Male 2002-11-10 0.00 ± 0.00 0.08 
RR00148 Adult Male 2003-11-05 0.00 ± 0.00 0.11 
RR00149 Adult Male 2002-03-16 0.00 ± 0.00 0.08 
RR00149 Adult Male 2002-11-10 0.00 ± 0.00 0.08 
RR00149 Adult Male 2003-11-21 0.16 ± 0.02 0.18 
RR00150 Adult Male 2002-03-16 0.00 ± 0.00 0.08 
RR00151 Adult Male 2002-03-30 0.00 ± 0.00 0.08 
RR00152 Adult Male 2002-08-02 0.28 ± 0.02 0.12 
RR00153 Adult Male 2002-10-20 0.08 ± 0.02 0.12 
RR00155 Adult Male 2002-03-17 0.00 ± 0.00 0.08 
RR00155 Adult Male 2002-05-23 0.00 ± 0.00 0.08 
RR00155 Adult Male 2002-08-26 0.00 ± 0.00 0.09 
RR00155 Adult Male 2002-10-18 0.11 ± 0.02 0.12 
RR00156 Adult Male 2002-02-03 0.00 ± 0.00 0.08 
RR00156 Adult Male 2002-03-19 0.00 ± 0.00 0.08 
RR00156 Adult Male 2002-07-27 0.00 ± 0.00 0.08 
RR00156 Adult Male 2002-08-21 0.00 ± 0.00 0.08 
RR00156 Adult Male 2002-10-12 0.05 ± 0.02 0.12 
RR00158 Adult Male 2002-03-13 0.50 ± 0.02 0.13 
RR00158 Adult Male 2002-07-28 0.40 ± 0.02 0.13 
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RR00158 Adult Male 2004-05-15 1.25 ± 0.06 0.21 
RR00158 Adult Male 2004-08-09 1.01 ± 0.06 0.23 
RR00158 Adult Male 2004-09-27 0.97 ± 0.05 0.22 
RR00159 Adult Male 2002-03-29 0.16 ± 0.02 0.11 
RR00159 Adult Male 2002-05-27 0.20 ± 0.02 0.13 
RR00159 Adult Male 2002-09-21 0.29 ± 0.02 0.13 
RR00159 Adult Male 2002-10-11 0.28 ± 0.02 0.13 
RR00168 Adult Male 2002-11-24 0.00 ± 0.00 0.08 
RR00170 Adult Male 2002-03-09 0.00 ± 0.00 0.08 
RR00170 Adult Male 2002-05-22 0.00 ± 0.00 0.08 
RR00170 Adult Male 2002-06-03 0.00 ± 0.00 0.08 
RR00170 Adult Male 2002-06-28 0.00 ± 0.00 0.08 
RR00174 Adult Male 2002-03-16 0.06 ± 0.02 0.11 
RR00175 Adult Male 2003-11-06 0.00 ± 0.00 0.11 
RR00176 Adult Male 2002-03-10 0.00 ± 0.00 0.08 
RR00176 Adult Male 2002-07-25 0.00 ± 0.00 0.08 
RR00176 Adult Male 2002-08-04 0.00 ± 0.00 0.08 
RR00176 Adult Male 2002-10-12 0.00 ± 0.00 0.08 
RR00177 Adult Male 2002-03-16 0.00 ± 0.00 0.08 
RR00178 Adult Male 2002-03-15 0.00 ± 0.00 0.08 
RR00178 Adult Male 2002-07-25 0.00 ± 0.00 0.08 
RR00180 Adult Male 2002-05-22 0.07 ± 0.02 0.11 
RR00180 Adult Male 2002-07-26 0.06 ± 0.02 0.12 
RR00180 Adult Male 2003-11-05 0.00 ± 0.00 0.11 
RR00182 Adult Male 2002-10-13 0.00 ± 0.00 0.08 
RR00182 Adult Male 2002-11-30 0.00 ± 0.00 0.08 
RR00184 Adult Male 2002-03-09 0.00 ± 0.00 0.08 
RR00185 Adult Male 2002-03-16 0.00 ± 0.00 0.08 
RR00185 Adult Male 2003-11-28 0.00 ± 0.00 0.11 
RR00187 Adult Male 2002-03-15 0.00 ± 0.00 0.08 
RR00187 Adult Male 2003-05-26 0.76 ± 0.03 0.13 
RR00187 Adult Male 2004-03-14 0.75 ± 0.05 0.21 
RR00187 Adult Male 2004-04-06 0.79 ± 0.05 0.21 
RR00187 Adult Male 2004-06-05 0.83 ± 0.05 0.21 
RR00187 Adult Male 2004-08-28 0.89 ± 0.05 0.20 
RR00187 Adult Male 2004-09-29 0.89 ± 0.05 0.21 
RR00187 Adult Male 2004-12-30 0.78 ± 0.08 0.34 
RR00188 Adult Male 2002-03-16 0.06 ± 0.01 0.08 
RR00189 Adult Male 2002-03-16 0.00 ± 0.00 0.08 
RR00189 Adult Male 2002-10-16 0.00 ± 0.00 0.08 
RR00189 Adult Male 2003-11-05 0.00 ± 0.00 0.11 
RR00190 Adult Male 2002-03-15 0.00 ± 0.00 0.08 
RR00190 Adult Male 2002-07-26 0.00 ± 0.00 0.08 
RR00190 Adult Male 2002-10-17 0.00 ± 0.00 0.08 
RR00190 Adult Male 2003-11-28 0.12 ± 0.02 0.17 
RR00191 Adult Male 2002-03-15 0.00 ± 0.00 0.08 
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RR00191 Adult Male 2003-11-28 0.00 ± 0.00 0.11 
RR00193 Adult Male 2002-03-14 0.00 ± 0.00 0.08 
RR00193 Adult Male 2002-06-03 0.00 ± 0.00 0.08 
RR00193 Adult Male 2002-07-26 0.00 ± 0.00 0.08 
RR00193 Adult Male 2003-11-06 0.00 ± 0.00 0.11 
RR00194 Adult Male 2002-03-16 0.00 ± 0.00 0.08 
RR00195 Adult Male 2002-03-16 0.07 ± 0.01 0.11 
RR00195 Adult Male 2003-12-30 0.00 ± 0.00 0.11 
RR00198 Adult Male 2002-03-15 0.00 ± 0.00 0.08 
RR00198 Adult Male 2002-05-23 0.00 ± 0.00 0.08 
RR00198 Adult Male 2002-07-28 0.00 ± 0.00 0.09 
RR00198 Adult Male 2002-10-14 0.00 ± 0.00 0.08 
RR00198 Adult Male 2004-03-22 0.42 ± 0.05 0.22 
RR00198 Adult Male 2004-04-06 0.41 ± 0.04 0.19 
RR00198 Adult Male 2004-05-13 0.44 ± 0.05 0.21 
RR00199 Adult Male 2002-05-27 0.08 ± 0.02 0.11 
RR00200 Adult Male 2002-02-03 0.06 ± 0.01 0.11 
RR00202 Adult Male 2003-07-19 0.00 ± 0.00 0.11 
RR00202 Adult Male 2003-09-01 0.09 ± 0.02 0.17 
RR00202 Adult Male 2003-12-08 0.27 ± 0.02 0.18 
RR00202 Adult Male 2004-02-04 0.38 ± 0.03 0.18 
RR00202 Adult Male 2004-02-28 0.77 ± 0.05 0.21 
RR00202 Adult Male 2004-03-14 0.64 ± 0.04 0.18 
RR00203 Adult Male 2002-02-03 0.09 ± 0.02 0.11 
RR00203 Adult Male 2002-03-18 0.00 ± 0.00 0.08 
RR00203 Adult Male 2002-05-22 0.00 ± 0.00 0.08 
RR00203 Adult Male 2003-12-01 0.07 ± 0.02 0.17 
RR00204 Adult Male 2002-02-03 0.29 ± 0.02 0.13 
RR00204 Adult Male 2002-03-13 0.09 ± 0.02 0.11 
RR00204 Adult Male 2002-07-26 0.00 ± 0.00 0.08 
RR00204 Adult Male 2002-10-12 0.00 ± 0.00 0.08 
RR00205 Adult Male 2002-02-03 0.00 ± 0.00 0.08 
RR00206 Adult Male 2002-02-03 0.00 ± 0.00 0.08 
RR00206 Adult Male 2002-03-31 0.00 ± 0.00 0.08 
RR00206 Adult Male 2002-06-09 0.00 ± 0.00 0.08 
RR00206 Adult Male 2002-10-13 0.00 ± 0.00 0.08 
RR00207 Adult Male 2002-02-03 0.00 ± 0.00 0.08 
RR00207 Adult Male 2002-03-15 0.10 ± 0.02 0.11 
RR00207 Adult Male 2002-06-03 0.00 ± 0.00 0.08 
RR00207 Adult Male 2002-07-24 0.26 ± 0.02 0.13 
RR00208 Adult Male 2002-03-09 0.00 ± 0.00 0.08 
RR00211 Adult Male 2002-03-16 0.00 ± 0.00 0.08 
RR00211 Adult Male 2002-07-27 0.00 ± 0.00 0.08 
RR00211 Adult Male 2002-10-21 0.00 ± 0.00 0.08 
RR00211 Adult Male 2002-11-17 0.00 ± 0.00 0.08 
RR00212 Adult Male 2002-03-16 0.00 ± 0.00 0.08 
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RR00212 Adult Male 2002-10-14 0.00 ± 0.00 0.08 
RR00213 Adult Male 2002-03-19 0.06 ± 0.02 0.11 
RR00213 Adult Male 2002-05-17 0.28 ± 0.02 0.13 
RR00213 Adult Male 2002-08-23 0.27 ± 0.02 0.12 
RR00213 Adult Male 2002-08-31 0.46 ± 0.02 0.13 
RR00213 Adult Male 2002-09-21 0.65 ± 0.03 0.13 
RR00213 Adult Male 2003-05-24 0.44 ± 0.02 0.13 
RR00214 Adult Male 2002-03-25 0.00 ± 0.00 0.08 
RR00214 Adult Male 2002-05-17 0.08 ± 0.02 0.12 
RR00214 Adult Male 2002-06-17 0.07 ± 0.02 0.11 
RR00215 Adult Male 2002-03-25 0.00 ± 0.00 0.07 
RR00215 Adult Male 2002-05-17 0.05 ± 0.01 0.10 
RR00215 Adult Male 2002-06-17 0.00 ± 0.00 0.08 
RR00215 Adult Male 2002-07-24 0.00 ± 0.00 0.08 
RR00219 Adult Male 2002-06-13 0.00 ± 0.00 0.08 
RR00219 Adult Male 2002-07-26 0.00 ± 0.00 0.08 
RR00220 Adult Male 2002-06-15 0.00 ± 0.00 0.08 
RR00220 Adult Male 2002-07-24 0.00 ± 0.00 0.08 
RR00220 Adult Male 2002-11-07 0.00 ± 0.00 0.08 
RR00221 Adult Male 2002-06-28 0.05 ± 0.02 0.12 
RR00221 Adult Male 2002-11-16 0.00 ± 0.00 0.08 
RR00222 Adult Male 2003-11-28 0.00 ± 0.00 0.11 
RR00226 Adult Male 2004-03-29 0.11 ± 0.03 0.13 
RR00228 Adult Male 2002-10-08 0.00 ± 0.00 0.08 
RR00228 Adult Male 2002-11-07 0.10 ± 0.02 0.13 
RR00229 Adult Male 2002-10-08 0.06 ± 0.02 0.11 
RR00230 Adult Male 2002-10-08 0.00 ± 0.00 0.08 
RR00230 Adult Male 2002-11-02 0.00 ± 0.00 0.08 
RR00231 Adult Male 2002-10-10 0.00 ± 0.00 0.08 
RR00232 Adult Male 2002-10-10 0.00 ± 0.00 0.08 
RR00232 Adult Male 2002-11-17 0.00 ± 0.00 0.08 
RR00233 Adult Male 2002-10-16 0.00 ± 0.00 0.08 
RR00234 Adult Male 2002-11-02 0.00 ± 0.00 0.08 
RR00237 Adult Male 2002-11-10 0.00 ± 0.00 0.08 
RR00238 Adult Female 2002-11-22 0.00 ± 0.00 0.08 
RR00239 Adult Male 2002-12-01 0.23 ± 0.02 0.12 
RR00240 Adult Male 2002-05-30 0.00 ± 0.00 0.08 
RR00240 Adult Male 2004-01-16 0.00 ± 0.00 0.11 
RR00241 Adult Male 2002-05-30 0.00 ± 0.00 0.08 
RR00241 Adult Male 2004-03-30 0.11 ± 0.03 0.14 
RR00242 Adult Male 2002-05-30 0.00 ± 0.00 0.08 
RR00243 Adult Male 2002-06-03 0.00 ± 0.00 0.08 
RR00243 Adult Male 2002-07-24 0.00 ± 0.00 0.08 
RR00243 Adult Male 2002-08-04 0.05 ± 0.02 0.13 
RR00243 Adult Male 2003-05-24 0.12 ± 0.02 0.13 
RR00243 Adult Male 2004-03-22 0.34 ± 0.04 0.20 
  A-9 
Table 1. Continued. 
 
137Cs (kBq) 
Personal ID # 
Age 
Type Gender 
Collection 
Date Value MDA 
 
RR00244 Adult Male 2002-06-03 0.00 ± 0.00 0.08 
RR00245 Adult Female 2002-09-17 0.00 ± 0.00 0.08 
RR00246 Adult Female 2002-08-02 0.00 ± 0.00 0.08 
RR00247 Adult Female 2002-08-02 0.00 ± 0.00 0.08 
RR00248 Adult Female 2002-08-02 0.00 ± 0.00 0.08 
RR00249 Adult Female 2002-08-02 0.00 ± 0.00 0.08 
RR00250 Adult Male 2002-08-10 0.00 ± 0.00 0.08 
RR00252 Adult Female 2002-08-18 0.00 ± 0.00 0.08 
RR00253 Adult Male 2002-11-03 0.00 ± 0.00 0.08 
RR00255 Child Male 2004-08-12 0.57 ± 0.05 0.20 
RR00255 Adult Male 2004-12-30 0.54 ± 0.08 0.35 
RR00256 Adult Male 2004-03-22 0.62 ± 0.05 0.20 
RR00256 Adult Male 2004-04-03 0.83 ± 0.05 0.22 
RR00256 Adult Male 2004-05-12 0.80 ± 0.05 0.20 
RR00256 Adult Male 2004-06-06 0.82 ± 0.05 0.22 
RR00256 Adult Male 2004-08-17 1.11 ± 0.06 0.23 
RR00256 Adult Male 2004-09-18 0.82 ± 0.05 0.22 
RR00256 Adult Male 2004-11-29 0.84 ± 0.05 0.21 
RR00256 Adult Male 2004-12-30 0.43 ± 0.07 0.32 
RR00258 Adult Male 2003-05-24 0.07 ± 0.02 0.14 
RR00258 Adult Male 2003-12-02 0.95 ± 0.04 0.18 
RR00259 Adult Male 2003-11-21 0.17 ± 0.02 0.18 
RR00263 Adult Male 2003-11-21 0.00 ± 0.00 0.11 
RR00267 Adult Male 2003-12-01 0.00 ± 0.00 0.11 
RR00270 Adult Male 2003-12-30 0.00 ± 0.00 0.11 
RR00274 Child Female 2004-08-12 0.08 ± 0.03 0.12 
RR00274 Child Female 2004-12-30 0.00 ± 0.00 0.11 
RR00275 Adult Female 2004-02-16 0.00 ± 0.00 0.11 
RR00275 Adult Female 2004-08-12 0.22 ± 0.04 0.20 
RR00275 Adult Female 2004-12-30 0.00 ± 0.00 0.11 
RR00276 Adult Male 2004-06-06 0.56 ± 0.05 0.20 
RR00276 Adult Male 2004-08-12 0.93 ± 0.05 0.21 
RR00276 Adult Male 2004-09-28 0.98 ± 0.06 0.25 
RR00279 Adult Male 2004-03-23 0.15 ± 0.03 0.13 
RR00280 Adult Male 2004-03-29 0.71 ± 0.06 0.26 
RR00281 Adult Male 2004-03-30 0.45 ± 0.04 0.19 
RR00282 Adult Male 2004-04-06 0.50 0.21 
RR00283 Adult Male 2004-08-09 0.00 ± 0.00 0.06 
RR00283 Adult Male 2004-08-16 0.00 ± 0.00 0.07 
RR00284 Adult Male 2004-09-17 0.06 ± 0.02 0.11 
RR00285 Adult Male 2004-09-17 0.09 ± 0.03 0.12 
RR00288 Adult Male 2004-06-04 0.16 ± 0.04 0.17 
RR00289 Adult Male 2004-09-18 0.00 ± 0.00 0.07 
RR00291 Adult Male 2004-09-26 0.22 ± 0.05 0.21 
RR00291 Adult Male 2004-11-29 0.41 ± 0.05 0.20 
RR00292 Adult Male 2004-09-26 0.11 ± 0.03 0.16 
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RR00293 Adult Male 2004-09-29 0.31 ± 0.04 0.19 
RR00310 Adult Male 2004-08-27 0.00 ± 0.00 0.07 
RR00310 Adult Male 2004-09-28 0.00 ± 0.00 0.07 
RR00356 Adult Male 2004-08-16 0.00 ± 0.00 0.07 
RR00561 Adult Female 2002-08-18 0.00 ± 0.00 0.08 
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Table 2. Plutonium urinalysis data for resettlement workers on Rongelap Island (CAMS/LLNL, 2002-
2004). 
 
239Pu (µBq) 
(µBq/24 h void) 
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ID # 
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Collection 
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RR00007 Adult Male 2003-06-24 0.60 ± 0.36 0.48 0.71 ± 0.77 1.61 
RR00007 Adult Male 2003-11-10 -0.03 ± 0.19 0.53 0.32 ± 0.54 1.55 
RR00026 Adult Male 2002-09-25 0.11 ± 0.21 0.48 0.66 ± 0.71 1.55 
RR00026 Adult Male 2003-07-25 0.34 ± 0.32 0.53 -0.16 ± 0.64 1.55 
RR00026 Adult Male 2003-11-07 -0.05 ± 0.40 0.49 -0.08 ± 1.42 2.61 
RR00029 Adult Male 2003-07-26 0.75 ± 0.40 0.53 -0.16 ± 0.60 1.55 
RR00029 Adult  Male 2003-11-06 -0.01 ± 0.20 0.53 -0.16 ± 0.60 1.55 
RR00030 Adult Male 2003-06-24 0.52 ± 0.32 0.48 0.63 ± 0.70 1.61 
RR00030 Adult Male 2003-11-12 0.16 ± 0.24 0.49 -0.08 ± 0.86 2.61 
RR00032 Adult Male 2002-04-30 -0.11 ± 0.25 0.61 0.00 ± 0.82 2.09 
RR00032 Adult Male 2003-06-24 0.55 ± 0.27 0.48 0.00 ± 0.51 1.61 
RR00034 Adult Male 2002-04-10 0.05 ± 0.17 0.61 0.00 ± 0.58 2.09 
RR00036 Adult Male 2003-11-10 -0.03 ± 0.19 0.53 -0.16 ± 0.52 1.55 
RR00038 Adult Male 2003-07-25 -0.05 ± 0.18 0.53 -0.16 ± 0.49 1.55 
RR00038 Adult Male 2003-11-07 0.09 ± 0.23 0.53 -0.16 ± 0.52 1.55 
RR00051 Adult Male 2003-11-13 0.13 ± 0.22 0.49 -0.08 ± 0.75 2.61 
RR00054 Adult Male 2002-04-08 0.25 ± 0.27 0.61 0.00 ± 0.64 2.09 
RR00057 Adult Male 2002-04-09 0.95 ± 0.38 0.61 0.94 ± 0.85 2.09 
RR00062 Adult Male 2003-01-17 0.06 ± 0.17 0.48 0.00 ± 0.59 1.55 
RR00066 Adult Male 2002-07-12 0.15 ± 0.19 0.48 0.00 ± 0.50 1.55 
RR00066 Adult Male 2003-10-21 0.01 ± 0.22 0.53 -0.16 ± 0.69 1.55 
RR00069 Adult Male 2003-07-27 0.27 ± 0.26 0.53 -0.16 ± 0.45 1.55 
RR00072 Adult Male 2003-07-27 0.50 ± 0.33 0.53 -0.16 ± 0.55 1.55 
RR00073 Adult Male 2003-07-25 0.73 ± 0.34 0.53 -0.16 ± 0.46 1.55 
RR00073 Adult Male 2003-11-11 -0.05 ± 0.23 0.49 -0.08 ± 0.83 2.61 
RR00088 Adult Male 2003-07-24 0.13 ± 0.25 0.53 0.81 ± 0.73 1.55 
RR00092 Adult Male 2003-07-24 0.82 ± 0.40 0.53 -0.16 ± 0.56 1.55 
RR00095 Adult Male 2002-04-11 -0.11 ± 0.16 0.61 0.00 ± 0.53 2.09 
RR00098 Adult Male 2003-01-17 0.05 ± 0.16 0.48 0.00 ± 0.55 1.55 
RR00111 Adult Male 2002-01-17 -0.08 ± 0.14 0.48 0.00 ± 0.49 1.55 
RR00111 Adult Male 2003-11-12 -0.05 ± 0.39 0.49 -0.08 ± 1.42 2.61 
RR00121 Adult Male 2002-07-12 0.43 ± 0.27 0.48 0.44 ± 0.52 1.55 
RR00122 Adult Male 2002-04-08 -0.11 ± 0.23 0.61 0.00 ± 0.81 2.09 
RR00123 Adult Male 2003-07-28 0.22 ± 0.30 0.53 -0.16 ± 0.73 1.55 
RR00123 Adult Male 2002-11-10 -0.05 ± 0.38 0.49 -0.08 ± 1.38 2.61 
RR00124 Adult Male 2002-04-30 0.07 ± 0.20 0.61 0.00 ± 0.67 2.09 
RR00124 Adult Male 2003-06-24 0.00 ± 0.18 0.48 0.00 ± 0.60 1.61 
RR00124 Adult Male 2003-11-07 -0.16 ± 0.22 0.53 -0.16 ± 0.64 1.55 
RR00125 Adult Male 2002-04-30 0.56 ± 0.31 0.61 0.00 ± 0.56 2.09 
RR00125 Adult Male 2003-10-21 0.06 ± 0.26 0.53 0.66 ± 0.86 1.55 
RR00126 Adult Male 2002-04-10 0.07 ± 0.19 0.61 0.00 ± 0.68 2.09 
RR00128 Adult Male 2003-11-12 -0.05 ± 0.23 0.49 0.62 ± 0.81 2.61 
RR00130 Adult Male 2002-04-30 0.56 ± 0.34 0.61 0.00 ± 0.64 2.09 
RR00130 Adult Male 2003-01-28 0.25 ± 0.25 0.48 0.00 ± 0.67 1.55 
RR00132 Adult Male 2002-09-25 0.26 ± 0.26 0.48 0.64 ± 0.69 1.55 
RR00132 Adult Male 2003-07-27 1.74 ± 0.62 0.53 1.81 ± 1.16 1.55 
RR00132 Adult Male 2003-11-11 -0.05 ± 0.58 0.49 -0.08 ± 2.04 2.61 
RR00136 Adult Male 2002-04-10 0.39 ± 0.36 0.61 0.00 ± 0.93 2.09 
RR00136 Adult Male 2003-01-28 0.62 ± 0.32 0.48 1.53 ± 0.92 1.55 
RR00137 Adult Male 2003-01-17 0.06 ± 0.16 0.48 0.00 ± 0.56 1.55 
RR00141 Adult Male 2002-04-09 0.42 ± 0.32 0.61 0.00 ± 0.66 2.09 
RR00141 Adult Male 2003-01-28 0.18 ± 0.20 0.48 0.00 ± 0.54 1.55 
RR00143 Adult Male 2002-04-08 0.19 ± 0.30 0.61 0.00 ± 1.02 2.09 
  A-12 
Table 2. Continued. 
 
239Pu (µBq) 
(µBq/24 h void) 
240Pu (µBq) 
(µBq/24 h void) 
Personal  
ID # 
  
Age 
Type 
 
Gender 
 
 
Collection 
Date 
 Value MDA Value MDA 
 
RR00143 Adult Male 2003-10-21 -0.16 ± 0.2 0.53 -0.16 ± 0.54 1.55 
RR00146 Adult Male 2002-07-16 0.45 ± 0.25 0.48 0.00 ± 0.47 1.55 
RR00150 Adult Male 2003-10-21 0.00 ± 0.21 0.53 -0.16 ± 0.63 1.55 
RR00152 Adult Male 2002-07-16 0.18 ± 0.20 0.48 0.00 ± 0.53 1.55 
RR00156 Adult Male 2002-07-12 0.19 ± 0.18 0.48 0.00 ± 0.43 1.55 
RR00157 Adult Male 2002-04-10 0.24 ± 0.26 0.61 0.00 ± 0.71 2.09 
RR00162 Adult Male 2002-07-16 0.25 ± 0.21 0.48 0.00 ± 0.49 1.55 
RR00168 Adult Male 2002-07-16 0.09 ± 0.19 0.48 0.64 ± 0.69 1.55 
RR00170 Adult Male 2002-08-01 0.03 ± 0.14 0.48 0.00 ± 0.49 1.55 
RR00174 Adult Male 2002-04-12 0.90 ± 0.42 0.61 0.59 ± 0.72 2.09 
RR00174 Adult Male 2003-07-01 0.00 ± 0.22 0.48 0.00 ± 0.74 1.61 
RR00179 Adult Male 2002-04-09 0.40 ± 0.31 0.61 0.65 ± 0.88 2.09 
RR00180 Adult Male 2002-04-08 -0.11 ± 0.22 0.61 0.00 ± 0.86 2.09 
RR00180 Adult Male 2003-03-11 0.00 ± 0.30 0.48 0.00 ± 1.12 1.61 
RR00185 Adult Male 2003-03-11 0.00 ± 0.24 0.48 0.00 ± 0.80 1.61 
RR00186 Adult Male 2002-04-09 -0.11 ± 0.21 0.61 0.00 ± 0.73 2.09 
RR00187 Adult Male 2002-08-01 0.33 ± 0.25 0.48 0.00 ± 0.57 1.55 
RR00187 Adult Male 2003-11-06 0.31 ± 0.31 0.53 -0.16 ± 0.61 1.55 
RR00189 Adult Male 2002-08-01 0.17 ± 0.20 0.48 0.00 ± 0.54 1.55 
RR00189 Adult Male 2002-03-11 0.45 ± 0.33 0.48 0.00 ± 0.85 1.61 
RR00190 Adult Male 2003-03-11 0.40 ± 0.30 0.48 0.00 ± 0.79 1.61 
RR00191 Adult Male 2003-10-14 0.15 ± 0.26 0.53 -0.16 ± 0.59 1.55 
RR00193 Adult Male 2003-10-14 0.58 ± 0.36 0.53 -0.16 ± 0.59 1.55 
RR00194 Adult Male 2002-08-01 0.22 ± 0.23 0.48 0.00 ± 0.60 1.55 
RR00198 Adult Male 2003-07-01 0.15 ± 0.18 0.48 0.00 ± 0.56 1.61 
RR00198 Adult Male 2003-11-06 0.01 ± 0.22 0.53 -0.16 ± 0.66 1.55 
RR00202 Adult Male 2002-04-30 0.05 ± 0.18 0.61 0.00 ± 0.64 2.09 
RR00202 Adult Male 2002-07-19 0.96 ± 0.40 0.48 0.55 ± 0.61 1.55 
RR00202 Adult Male 2003-08-09 0.21 ± 0.21 0.16 0.40 ± 0.58 1.42 
RR00202 Adult Male 2003-08-13 0.18 ± 0.19 0.16 -0.13 ± 0.52 1.42 
RR00202 Adult Male 2003-10-14 -0.16 ± 0.19 0.53 -0.16 ± 0.52 1.55 
RR00202 Adult Male 2003-11-06 1.18 ± 0.47 0.53 -0.16 ± 0.60 1.55 
RR00203 Adult Male 2002-07-12 0.18 ± 0.21 0.48 0.00 ± 0.56 1.55 
RR00206 Adult Male 2003-07-28 0.17 ± 0.27 0.53 -0.16 ± 0.64 1.55 
RR00206 Adult Male 2003-11-10 -0.05 ± 0.39 0.49 -0.08 ± 1.43 2.61 
RR00207 Adult Male 2002-09-25 0.05 ± 0.15 0.48 0.00 ± 0.54 1.55 
RR00208 Adult Male 2003-10-14 0.69 ± 0.35 0.53 -0.16 ± 0.50 1.55 
RR00211 Adult Male 2003-07-01 0.25 ± 0.21 0.48 0.00 ± 0.53 1.61 
RR00211 Adult Male 2003-11-10 -0.16 ± 0.19 0.53 -0.16 ± 0.53 1.55 
RR00213 Adult Male 2003-07-24 0.09 ± 0.29 0.53 0.76 ± 0.96 1.55 
RR00213 Adult Male 2003-11-07 0.11 ± 0.30 0.53  -0.16 ± 1.02 1.55 
RR00222 Adult Male 2002-04-11 0.92 ± 0.37 0.61 0.46 ± 0.57 2.09 
RR00223 Adult Male 2002-04-11 0.39 ± 0.36 0.61 0.00 ± 1.05 2.09 
RR00224 Adult Male 2002-04-11 -0.11 ± 0.15 0.61 0.00 ± 0.57 2.09 
RR00225 Adult Male 2002-04-12 0.15 ± 0.27 0.61 0.00 ± 1.02 2.09 
RR00226 Adult Male 2002-04-12 0.05 ± 0.18 0.61 0.59 ± 1.05 2.09 
RR00227 Adult Male 2002-04-12 0.03 ± 0.16 0.61 0.00 ± 0.56 2.09 
RR00233 Adult Male 2003-07-01 0.38 ± 0.24 0.48 0.44 ± 0.54 1.61 
RR00237 Adult Male 2003-03-05 1.90 ± 0.68 0.48 2.49 ± 1.47 1.61 
RR00243 Adult Male 2003-11-07 -0.16 ± 0.25 0.53 -0.16 ± 0.78 1.55 
RR00253 Adult Male 2003-03-05 0.41 ± 0.30 0.48 0.00 ± 0.80 1.61 
RR00256 Adult Male 2003-11-06 0.40 ± 0.31 0.53 -0.16 ± 0.54 1.55 
RR00258 Adult Male 2003-07-24 0.78 ± 0.41 0.53 0.39 ± 0.61 1.55 
RR00258 Adult Male 2003-11-13 0.25 ± 0.32 0.49 -0.08 ± 1.15 2.61 
  A-13 
 
Table 2. Continued. 
 
239Pu (µBq) 
(µBq/24 h void) 
240Pu (µBq) 
(µBq/24 h void) 
Personal  
ID # 
  
Age 
Type 
 
Gender 
 
 
Collection 
Date 
 Value MDA Value MDA 
 
RR00259 Adult Male 2003-11-10 -0.05 ± 0.39 0.49 -0.08 ± 1.42 2.61 
RR00260 Adult Male 2003-11-10 -0.05 ± 0.29 0.49 1.80 ± 1.39 2.61 
RR00279 Adult Male 2003-11-13 0.68 ± 0.38 0.49 -0.08 ± 0.77 2.61 
 
